Direct HIV testing in blood donations: Variation of the yield with detection threshold and pool size

Transfusion

Volumn 39, Issue 10, 1999, Pages 1141-1144

  Le Corfec, E ^b   Le Pont, F ^a   Tuckwell, H C ^b   Rouzioux, C ^b   Costagliola, D ^b  

^a INSERM   (France)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN P24; VIRUS ANTIBODY;

ANTIBODY DETECTION; ARTICLE; BLOOD DONOR; COST EFFECTIVENESS ANALYSIS; FRANCE; GENE AMPLIFICATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION PREVENTION; MATHEMATICAL MODEL; PREDICTION; UNITED STATES;

BLOOD DONORS; DIFFERENTIAL THRESHOLD; FRANCE; GENE AMPLIFICATION; HIV ANTIBODIES; HIV INFECTIONS; HIV-1; HUMANS; MODELS, BIOLOGICAL; RNA, VIRAL; TIME FACTORS; UNITED STATES;

EID: 0032850347     PISSN: 00411132     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1537-2995.1999.39101141.x     Document Type: Article

References (15)

1. Busch MP, Lee LLL, Satten GA, et al. Time course of detection of viral and serologic markers preceding human immunodeficiency virus type 1 seroconversion: implications for screening of blood and tissue donors. Transfusion 1995;35:91-7.
2. Barbara J. Benefit of using polymerase chain reaction to test blood donations will be considerable (letter). BMJ 1997;315:60.
3. Legge A. Direct HIV testing of donated blood is inevitable (news). BMJ 1997;314:1437.
4. Le Corfec E, Tuckwell HC. Variability in early HIV-1 population dynamics (letter). AIDS 1998;12:960-2.
5. Tuckwell HC, Le Corfec E. A stochastic model for early HIV-1 population dynamics. J Theor Biol 1998;195:451-63.
6. Phillips AN. Reduction of HIV concentration during acute infection: independence from a specific immune response. Science 1996;271:497-9.
7. Piatak M Jr., Saag MS, Yang LC, et al. High levels of HIV-1 in plasma during all stages of infection determined by competitive PCR. Science 1993;259:1749-54.
8. Tuckwell HC. Elementary applications of probability theory: with an introduction to stochastic differential equations. London: Chapman & Hall, 1995.
9. Le Pont F, Costagliola D, Rouzioux C, Valleron AJ. How much would the safety of blood transfusion be improved by including p24 antigen in the battery of tests? Transfusion 1995;35:542-7.
10. Schreiber GB, Busch MP, Meinman SH, Korelitz JJ. The risk of transfusion-transmitted viral infections. The Retrovirus Epidemiology Donor Study. N Engl J Med 1996;334:1685-90.
11. Sperling RS, Shapiro DE, Coombs RW, et al. Maternal viral load, zidovudine treatment, and the risk of transmission of human immunodeficiency virus type 1 from mother to infant. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group. N Engl J Med 1996;335:1621-9.
12. Kemper M, Witt D, Madsen T, et al. The effect of dilution on the outcome of pooled plasma testing with HIV type 1 (HIV-1) RNA genome amplification as compared to the outcome of individual-unit testing with other HIV-1 markers. Transfusion 1998;38:469-72.
13. AuBuchon JP, Birkmeyer JD, Busch MP. Cost-effectiveness of expanded human immunodeficiency virus-testing protocols for donated blood. Transfusion 1997;37:45-51.
14. Mortimer J. Intersecting pools and their potential application in testing donated blood for viral genomes. Vox Sang 1997;73:93-6.
15. Hewlett IK, Epstein JS. Food and Drug Administration Conference on the Feasibility of Genetic Technology to Close the HIV Window in Donor Screening. Transfusion 1997;37:346-54.